Park 24 (PKCOY) 33.7510 $PKCOY Park24 and Toyota to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Park 24 (PKCOY) 33.7510 $PKCOY

Park24 and Toyota to Improve and Expand Tokyo Car Sharing Service Trial
M2 - Tue Sep 29, 4:51AM CDT
Starting next month, Park24 Co., Ltd. and Toyota Motor Corporation will expand the scope and scale of their joint car sharing service trial in central . In addition to continuing to use the Toyota i-Road, the service will now also make use of the COMS, a super-compact electric vehicle produced by Toyota Auto Body. A number of new locations have been added throughout central , and the service's vehicle management system has been overhauled with several user-friendly updates. This phase of the trial is planned to run from October 20 through to the end of March 2016.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Celebrating Innovative Thought Leadership: TLFT 2025 Awards

Updated Category News Views 401

Celebrating Innovative Thought Leadership Accenture, KPMG, and Elsevier have been honored for their groundbreaking accomplishments in thought leadership, showcasing their significant influence across brand development, social impact, and industry standards. Recognition at the TLFT 2025 Awards iResearch Services has proudly unveiled the winners of the prestigious TLFT 2025...

Continue Reading
Aquestive Therapeutics Boosts Stock Target After Event Insights

Updated Category News Views 57

Aquestive Therapeutics made headlines back in 2024 with its stock getting a price target bump to $10 from H.C. Wainwright. This was right after they rolled out updates at a virtual investor event where they pitched their cutting-edge Adrenaverse technology. Traders were buzzing—was this the kind of news that’d drive shares up? Turns out, it was more than just fluff;...

Continue Reading
Valneva Collaborates with LimmaTech on Shigella Vaccine Study

Updated Category News Views 63

Valneva Begins Clinical Trials for Innovative Shigella Vaccine Valneva SE, a prominent specialty vaccine company, and LimmaTech Biologics AG, a clinical-stage biotech firm, have recently marked a significant milestone in vaccine research. They announced the initial vaccination in a pivotal Phase 2b controlled human infection model (CHIM) study focused on their tetravalent...

Continue Reading
Innovative Vehicle Accessory Enhances Road Safety Efforts

Updated Category News Views 194

Introducing a Revolutionary Vehicle Safety Accessory Every day, drivers encounter various challenges on the road, from navigating busy intersections to spotting pedestrians or hidden traffic signs. An innovative inventor recognized these challenges and developed the CORNER CAMERA, an inventive solution aimed at improving road safety for everyone. Understanding the CORNER...

Continue Reading
California Northstate University Celebrates Key Accreditation Milestone

Updated Category News Views 159

California Northstate University Announces Full Accreditation California Northstate University (CNU) has achieved a significant milestone by securing full accreditation for its College of Medicine from the Liaison Committee on Medical Education (LCME). This achievement underscores CNU’s unwavering dedication to promoting educational excellence, innovation, and the...

Continue Reading